Cargando…
Development of Complement Factor H–Based Immunotherapeutic Molecules in Tobacco Plants Against Multidrug-Resistant Neisseria gonorrhoeae
Novel therapeutics against the global threat of multidrug-resistant Neisseria gonorrhoeae are urgently needed. Gonococci possess several mechanisms to evade killing by human complement, including binding of factor H (FH), a key inhibitor of the alternative pathway. FH comprises 20 short consensus re...
Autores principales: | Shaughnessy, Jutamas, Tran, Y, Zheng, Bo, DeOliveira, Rosane B., Gulati, Sunita, Song, Wen-Chao, Maclean, James M., Wycoff, Keith L., Ram, Sanjay |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7649208/ https://www.ncbi.nlm.nih.gov/pubmed/33193396 http://dx.doi.org/10.3389/fimmu.2020.583305 |
Ejemplares similares
-
An optimized Factor H-Fc fusion protein against multidrug-resistant Neisseria gonorrhoeae
por: Shaughnessy, Jutamas, et al.
Publicado: (2022) -
α-2,3-Sialyltransferase Expression Level Impacts the Kinetics of Lipooligosaccharide Sialylation, Complement Resistance, and the Ability of Neisseria gonorrhoeae to Colonize the Murine Genital Tract
por: Lewis, Lisa A., et al.
Publicado: (2015) -
Binding of Complement Factor H to Loop 5 of Porin Protein 1A: A Molecular Mechanism of Serum Resistance of Nonsialylated Neisseria gonorrhoeae
por: Ram, Sanjay, et al.
Publicado: (1998) -
Complement alone drives efficacy of a chimeric antigonococcal monoclonal antibody
por: Gulati, Sunita, et al.
Publicado: (2019) -
Targeting Lipooligosaccharide (LOS) for a Gonococcal Vaccine
por: Gulati, Sunita, et al.
Publicado: (2019)